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ABSTRACT
Introduction Self- management and remaining physically 
active are first- line recommendations for the care of 
patients with low back pain (LBP). With a lifetime prevalence 
of up to 85%, novel approaches to support behavioural 
self- management are needed. Internet interventions may 
provide accessible support for self- management of LBP 
in primary care. The aim of this randomised controlled 
trial is to determine the clinical and cost- effectiveness of 
the ‘SupportBack’ internet intervention, with or without 
physiotherapist telephone support in reducing LBP- related 
disability in primary care patients.
Methods and analysis A three- parallel arm, multicentre 
randomised controlled trial will compare three arms: (1) 
usual primary care for LBP; (2) usual primary care for LBP 
and an internet intervention; (3) usual primary care for LBP 
and an internet intervention with additional physiotherapist 
telephone support. Patients with current LBP and no 
indicators of serious spinal pathology are identified and 
invited via general practice list searches and mailouts or 
opportunistic recruitment following LBP consultations. 
Participants undergo a secondary screen for possible 
serious spinal pathology and are then asked to complete 
baseline measures online after which they are randomised 
to an intervention arm. Follow- ups occur at 6 weeks, 3, 6 
and 12 months. The primary outcome is physical function 
(using the Roland and Morris Disability Questionnaire) 
over 12 months (repeated measures design). Secondary 
outcomes include pain intensity, troublesome days in pain 
over the last month, pain self- efficacy, catastrophising, 
kinesophobia, health- related quality of life and cost- related 
measures for a full health economic analysis. A full mixed- 
methods process evaluation will be conducted.
Ethics and dissemination This trial has been approved 
by a National Health Service Research Ethics Committee 
(REC Ref: 18/SC/0388). Results will be disseminated 
through peer- reviewed journals, conferences, 
communication with practices and patient groups. Patient 
representatives will support the implementation of our full 
dissemination strategy.
Trial registration number ISRCTN14736486.
INTRODUCTION
Low back pain (LBP) has a lifetime prevalence 
of up to 85%1 and is the greatest single cause 
of years lived with disability globally.2 LBP is 
primarily managed in primary care,3 where 
first- line recommendations are to self- manage 
and remain physically active.4 Supporting 
effective behavioural self- management of 
LBP is increasingly important; the most 
recent guidelines place less emphasis on 
pharmacological and surgical treatments.5 
General practitioners (GPs) are unlikely to 
have the training or the capacity to support 
behavioural self- management, and access to 
specialist musculoskeletal (MSK) services 
can be variable.6 New roles such as First 
Contact Physiotherapists in general practice 
Strengths and limitations of this study
 ► The SupportBack 2 trial is a large multicentre ran-
domised trial that will determine the additional ben-
efit, over usual primary care, of an internet- based 
approach that supports self- management of pa-
tients with low back pain (LBP) in UK primary care.
 ► The trial is designed to investigate the effectiveness 
of an internet intervention in addition to usual pri-
mary care, both with and without telephone physio-
therapist support.
 ► A full mixed- methods process evaluation will be 
carried out to inform a logic model and ‘theory of 
change’ for the interventions.
 ► Inclusion is limited to those with LBP who have ac-
cess to the internet and are able to communicate in 
English without assistance.
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are emerging, but implementation is at an early stage.7 
Internet interventions may offer a route to rapidly scal-
able behavioural support for patients with LBP, however, 
their effectiveness in UK primary care needs to be 
determined.
Internet interventions are typically automated, interac-
tive, tailored interventions that make use of multimedia 
formats to deliver behavioural change strategies online.8 
Internet interventions are one form of a broader cate-
gory of digital interventions that draw on digital tech-
nologies including the internet, mobile devices and 
activity sensors.9 A recent systematic review of digital 
interventions for LBP highlighted substantial heteroge-
neity in intervention delivery, duration and outcomes, 
making it difficult to draw conclusions regarding effec-
tiveness.10 Since the publication of this review, there 
has been a focus on mobile apps for LBP: a German 
study has shown that a mobile app delivering multidisci-
plinary self- management support for patients with LBP 
recruited via online advertising significantly reduced 
pain at 12- week follow- up, compared with a 6- week 
course of exercise delivered by physiotherapists plus 
online education.11 An ongoing European programme 
of work seeks to determine the effectiveness of a mobile 
app- based digital decision support self- management 
programme (selfBACK) for patients recently consulting 
in primary care for LBP.12 While mobile apps show 
potential, internet interventions likely have an accessi-
bility advantage; they can be accessed from any device 
with an internet connection (eg, desktop, laptop, tablet, 
mobile phone).
SupportBack is an internet intervention designed 
to support patients to self- manage their LBP following 
consultation in primary care.13 14 It was developed using 
evidence and theory in combination with the person- 
based approach, where systematic qualitative research is 
integrated throughout development.15 16 SupportBack is 
designed to be as accessible as possible, both in presen-
tation style and in target; it can be used by people with 
both acute and persistent LBP. SupportBack has been 
developed to be used in addition to usual care, either as 
a stand- alone internet intervention or in combination 
with physiotherapist telephone support. A randomised 
controlled feasibility trial demonstrated both the feasi-
bility of trial procedures and the effective delivery of the 
intervention and telephone support.14 In a nested qual-
itative study within the feasibility trial, Geraghty et al15 
found that patients were broadly positive about the inter-
vention; they suggested that it provided reassurance while 
supporting becoming more physically active as a primary 
pain management strategy.
The aim of the present full randomised controlled trial 
(RCT) is to determine the clinical and cost- effectiveness 
of the SupportBack internet intervention, delivered in 
addition to usual care with and without physiotherapist 
telephone support, in reducing LBP- related physical 
disability in UK primary care.
METHODS
Design
A three- parallel arm (1:1:1), multicentre RCT is being 
conducted to determine the clinical and cost- effectiveness 
of an internet intervention for patients with LBP in 
primary care. Participants will be followed up at 6 weeks, 
3, 6 and 12 months.
Study setting
The trial is being carried out with patients from 140 to 
180 general practices across the UK. Patients access the 
intervention through their own devices with internet 
access (eg, a desktop, laptop, tablet, mobile phone) at a 
location that is convenient for them (eg, at home or at 
work). If allocated to receive telephone physiotherapist 
support, this support is delivered wherever is convenient 
for the patient. A list of patient identification centres is 
available from the trial team on request.
Eligibility criteria
Inclusion criteria
 ► Aged 18 and above.
 ► Current LBP (have experienced pain in the last week) 
with or without sciatica.
 ► Access to the internet and an active email address.
 ► Ability to read/understand English without assistance.
 ► Ability to provide informed consent.
Exclusion criteria
 ► Signs and symptoms in a patient with LBP that indi-
cate potential serious spinal pathology such as infec-
tion, malignancy, fracture, inflammatory back pain, 
progressive neurology and/or cauda equina.
 ► Have had spinal surgery in the past 6 months.
 ► Pregnancy.
 ► Taken part in the prior SupportBack feasibility study.
Identification, recruitment and screening
Two recruiting centres, Southampton and Keele (each 
with a team of telephone support physiotherapists) are 
working with National Institute for Health Research Clin-
ical Research Networks to facilitate the recruitment of 
general practices. Potentially eligible participants will be 
identified in one of two ways:
1. Patients who have consulted with LBP in the last 
2 months will be identified by general practice staff 
from computerised records of consultations. Practices 
will be asked to repeat the searches approximately 
three times, or until the target number of patients per 
practice has been reached. Resulting lists of patients 
identified by the search will be screened by a practice 
GP who will rule out patients based on aspects of the 
eligibility criteria that can be determined from patient 
notes.
2. During a patient consultation and on entering a rel-
evant diagnostic or symptom Read code into the pa-
tient electronic medical record, GPs will be prompted 
about the trial and patient eligibility by an automated 
‘pop- up’ screen activated by the Read code. GPs will 
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then screen for eligibility (using the inclusion/exclu-
sion criteria listed) and patients identified as suitable 
will have their medical record electronically tagged. A 
download of ‘tagged’ patients will occur regularly, an-
ticipated to be every 2 weeks. This method will be used 
in practices where possible. Participating general prac-
tices not implementing the ‘pop up’ Read code meth-
od can identify potential patients during consultation. 
Having considered eligibility the GP or nurse practi-
tioner will provide the patient with an invitation pack.
Patients identified either by a medical records review 
or general practice consultation are mailed a study pack 
including an invitation letter from the GP, participant 
information sheet, reply slip, screening questions and 
prepaid envelope. Interested patients return the reply 
slip and screening questions using the prepaid envelope 
to the research team. Screening consists of two questions 
regarding current LBP and access to the internet, followed 
by three safety questions listing symptoms that may indi-
cate serious spinal pathology. Patients who answer ‘yes’ 
to the first two questions, and ‘no’ to all safety questions, 
are considered eligible. For those who complete the 
screening questions and fail safety screening, a physiother-
apist contacts the patient to make an appropriate clinical 
recommendation on hearing a further description of the 
symptoms. Those who fail the screening are documented 
on a screening log maintained by the research team. All 
patients considered eligible for the trial are assigned a 
unique participant identification number and sent a link 
to the study website, to complete consent, baseline ques-
tionnaires and be randomised. Recruitment opened in 
November 2018 and is expected to close in December 
2020, with data collection completing approximately 12 
months later in December 2021.
Randomisation, allocation and blinding
The randomisation process for this trial is fully auto-
mated. The intervention and data collection software 
automatically generates the randomisation sequence, and 
a computer- generated algorithm block randomises partic-
ipants to the trial groups. Participants are being stratified 
by trial recruiting centre and level of physical function: 
a score of less than four on the Roland Morris Disability 
Questionnaire (RMDQ17) is being used to denote a lower 
level of self- rated physical disability. As the automated soft-
ware randomises patients, the randomisation sequence is 
concealed from the trial team. Patients are automatically 
informed of their group allocation through the internet 
intervention software. As patients are engaging with a 
behavioural intervention, they are not blind to allocation. 
The majority of data will be collected online, or by post. 
Telephone calls are used to collect primary outcome data 
where there has been no response to online and postal 
follow- up. The callers are blind to group allocation. The 
statisticians conducting the analyses will remain blind to 
group allocation. The health economist will conduct the 
majority of analysis blinded to group, however, estimates 
of total cost require the addition of costs specific to the 
provision of the interventions so will become unblinded 
at this point. Figure 1 details patient flow through the 
trial.
Interventions
Usual care
Participants randomised to this arm will continue to 
receive unrestricted usual primary care for LBP. Current 
National Institute for Health and Care Excellence recom-
mendations for primary care management of LBP suggest 
assessment to rule out specific spinal pathology and use of 
risk stratification tools (eg, STarT Back18). Guidelines with 
regard to pharmacotherapy recommend Non- steroidal 
anti- inflammatory drugs (NSAIDs) at the lowest effective 
doses for the shortest period of time. Paracetamol and 
opiates are not recommended for routine use. Care may 
also include referrals for physiotherapy and psycholog-
ical interventions such as cognitive–behavioural therapy. 
Despite guidelines, there is likely to be a variety in what 
is provided for patients as part of usual care over the trial 
period from no further contacts, to referrals to phys-
iotherapy and pain clinics. Consequently, healthcare 
resource use will be documented and form a central part 
of our health economic analysis.
Usual care+internet intervention
Participants randomised to this arm will continue to 
receive unrestricted usual primary care. In addition, they 
will have access SupportBack. SupportBack is a multi-
session, interactive internet intervention that provides 
participants with accessible information, advice and 
tools to support the effective self- management of LBP. 
The SupportBack intervention (including telephone 
support) has been extensively described elsewhere.13 15 In 
brief, the central components of the intervention include 
graded goal setting, self- monitoring and tailored feed-
back to encourage physical activity (PA)/exercise 
increases or maintenance. SupportBack also provides 
educational modules regarding pain and LBP- related 
topics (relieving pain; flare ups; work; sleep; mood; daily 
living). Throughout the digital material, there is a focus 
on supporting motivation for behavioural change: Tech-
niques employed include reassuring about consequences 
of movement, modelling of use of activity as a primary 
pain management strategy and using automation to 
deliver positive feedback through reassurance regarding 
consequences. These techniques were combined with a 
person- based approach in the development of Support-
Back, where the application of such approaches was 
guided by systematic in- depth qualitative research with 
patients with LBP.16
Practically, patients can access SupportBack from any 
device with an internet connection from wherever is 
most convenient for them. SupportBack consists of six 
sessions, and patients are encouraged to log in and use 
one session per week. Automated reminders adhere to 
this schedule. The first session highlights the centrality 
of PA in managing LBP, and supports patients to set goals 
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to either walk more, or engage with a range of gentle 
back exercises of their choice. Goal options are tailored 
and are based the extent that patients report their LBP 
obstructs their day- to- day activities. The further sessions 
feature self- monitoring and feedback regarding their 
progress with walking or exercise goals, combined with 
Figure 1 Flow through the trial. CARE, Congratulate, Ask, Reassure, Encourage; GP, general practitioner; LBP, low back pain; 
PIS, Patient Information Sheet.
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encouragement from SupportBack to continue. After 
the first session, patients can unlock one further module 
per week on topics such as sleep, mood and work. These 
build into a personal repository, that alongside weekly 
goals, can be accessed at any time. If engaged with weekly, 
the tailored, interactive part of the intervention will last 
6 weeks. Following completion of all the sessions, Support-
Back converts into static resource where all activities/
exercises and modules can be accessed for the duration 
of the trial.
Usual care+internet intervention+telephone physiotherapist 
support
Participants randomised to this arm will also continue 
to receive unrestricted usual primary care, with access to 
the SupportBack internet intervention. In addition, these 
participants will also receive up to 1 hour of physiothera-
pist support over the telephone (the first call can be up 
to 30 min, with two follow- up calls of up to 15 min, over 
the 6- week intervention period). At both centres (South-
ampton and Keele) support is provided by MSK physiother-
apists working in the National Health Service (NHS).
The objectives of the telephone contact are to encourage 
the use of the SupportBack intervention, provide reassur-
ance regarding LBP and encourage adherence to PA goals. 
The physiotherapists are asked to closely adhere to a stan-
dardised content checklist for each phone call. The check-
list follows the Congratulate, Ask, Reassure, Encourage 
approach,19 developed specifically to guide support for 
digital interventions. Drawing on existing clinical skills, 
it ensures a general supportive approach and requires 
minimal training (all support physiotherapists attended a 
2- hour training session ahead of the trial). While telephone 
physiotherapists are able to address individual participant 
concerns, they are asked to avoid additional individualised 
participant assessment and treatment recommendations 
beyond the internet intervention content. Physiotherapists 
complete a checklist for each call. Checklists are returned 
to the trial coordinating centre, where intervention fidelity 
will be assessed.
Measures
All measures and time points for collection are listed in 
table 1.
Primary outcome
The primary outcome in this trial is LBP- related physical 
function measured with the RMDQ.17 Function forms a 
central domain in the recommended core outcomes set 
for LBP trials.20 The RMDQ is a recommended measure 
of physical function21 and is commonly used in primary 
care LBP trials.
Secondary measures
Demographic data are being collected at baseline 
including age, sex, educational attainment, marital and 
occupational status. A range of secondary measures 
are being collected including pain intensity,22 number 
of troublesome days in pain23 and risk of pain related 
disability,24 Pain- related psychological variables are being 
measured including kinesiophobia (fear of movement),25 
catastrophising,26 pain self- efficacy (SE),27 outcome 
expectations28 and symptoms of depression and anxiety.29 
General PA is being measured with the Godin Leisure- 
time Exercise Questionnaire30 in this trial; the short- form 
International Physical Activity Questionnaire31 was used 
in the feasibility trial but produced unreliable data. We 
are also measuring intervention specific PA with a single 
item developed for this trial. Adherence to walking and 
PA goals are being measured with specifically developed 
items, based closely on measures previously used in a 
related behavioural trial32 and difficulties with the inter-
vention are being measured using the Problematic Expe-
riences of Therapy Scale.33
To support the health economic analysis health- related 
quality of life is being measured with the 5- level EQ- 5D 
(EQ- 5D- 5L)34 All resources required to provide the 
internet intervention and the telephone support will be 
recorded. Details of NHS resource use will be recorded 
from general practice notes review. This will include both 
primary and secondary care contacts and will cover both 
general healthcare usage in addition to LBP specific care 
in the follow- up period. Additionally, LBP- specific medi-
cation use will be captured. There may also be differences 
in LBP related services paid for by study participants: for 
example, complementary or complementary medicine. 
Participants may also require time off work. Additionally, 
there may be under- reporting of LBP- specific resource use 
from medical records. These resources will be captured 
by means of a simple questionnaire administered at six 
and 12 months. The time- off work question and items 
relating to use of private healthcare will additionally be 
asked at baseline. All resources identified will be costed 
using appropriate local and national data, for example, 
NHS reference costs and Unit Costs of Health and Social 
Care. Occupational status is being measured with a brief 
questionnaire developed for this trial.
The internet intervention software automatically 
collects data on number of logins, page and module views 
and time spent in each login. This data will be used to 
explore adherence and user engagement to the digital 
component of the intervention.
Sample size
The reported minimally clinical important difference 
(MCID) between groups for the RMDQ varies. A between 
group MCID of 2 or 3 points is commonly reported.23 35 36 
However, it has been suggested that a difference of 1.5 
may still be important, particularly in the context of low 
intensity interventions.23 Whether delivered as a stand- 
alone intervention or coupled with brief telephone 
support, SupportBack is a low intensity intervention with 
the potential to be rapidly scalable. Consequently, we 
considered a between group change of at least 1.5 to be 
a meaningful difference in this context. For our repeated 
measures primary outcome, a difference of 1.5 points 
on the RMDQ over the follow- up period of 12 months, 
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Table 1 Outcomes and measures used in the trial
Domain Measure Time point
Function (primary outcome)
LBP- related physical function Roland Morris Disability Questionnaire.17 Baseline, 6 weeks, 3, 6, 12 months. All 
arms.
Pain
Pain intensity Pain index (Numerical Rating Scales 
measuring current, average and least 
pain over the last 2 weeks).22
Baseline, 6 weeks, 3, 6, 12 months. All 
arms.
Pain duration Time since last pain- free month.45 Baseline. All arms.
Troublesomeness of pain Troublesome days in pain over the last 
month(developed from days in pain 
measure.23
Baseline, 6 weeks, 3, 6, 12, months. All 
arms.
Risk of persistent pain- related disability STarT Back tool.24 Baseline, 12 months. All arms.
Psychological processes related to pain
Fear of movement Tampa Scale for Kinesiophobia.25 Baseline, 12 months.
All arms.
Catastrophising/negative orientation 
towards pain
Pain Catastrophizing Scale.26 Baseline, 12 months follow- up
All arms.
Confidence in ability to manage pain Pain Self- Efficacy Questionnaire.27 Baseline, 6 weeks, 12 months. All arms.
Self- efficacy for managing LBP Single item from Musculoskeletal Health 
Questionnaire.46
Baseline, 6 weeks, 3, 6, 12 months. All 
arms.
Outcome expectation Expectancy question from Credibility and 
Expectancy Questionnaire modified for 
LBP modification.28 47
Baseline, all arms. following session one 
of SupportBack
Internet intervention arms only.
Mental health Patient Health Questionnaire-429 
depression and anxiety measure.
Baseline, 12 months. All arms.
Physical activity/adherence
General physical activity Godin leisure- time exercise 
questionnaire.30
Baseline, 12 months. All arms
SupportBack- related physical activity Single item measure developed for the 
trial.
Baseline, 6 weeks, 3, 6, 12 months. All 
arms.
Adherence to back- specific activity Item developed for this trial, based 
on previous behavourial adherence 
measures.32
12 months. All arms
Difficulties with intervention 
recommendations
Problematic Experiences of Therapy 
Scale.33
12 months.
Internet intervention arms only.
Satisfaction and enablement
Satisfaction with care received for LBP Single satisfaction item developed for 
trial.
6 weeks. All arms.
Enablement Patient Enablement Instrument.48 6 weeks, 12 months. All arms.
Health related quality of life, healthcare resource use and occupational status
Health- related quality of life ED- 5D- 5L.34 Baseline, 6 weeks, 3, 6, 12 months. All 
arms.
Use of over- the- counter (OTC) 
medication for LBP
Single item measuring self- reported OTC 
medication usage for LBP.
Baseline, 6 months, 12 months. All arms.
Participant borne costs Participant reported health resource use 
questionnaire developed for this study.
Baseline, 6 months, 12 months. All arms.
NHS healthcare resource use (specific to 
back pain, and general)
General practice medical notes review 
and participant reported healthcare 
resource use questionnaire developed for 
this trial.
Baseline, 6 months, 12 months. All arms.
Continued
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assuming an SD of 5 in line with the feasibility study,23 
gives an effect size of 0.30. Alpha will be set to 0.025 to 
allow both interventions to be independently compared 
with the usual care alone arm. Using four repeated 
measures (6 weeks, 3, 6 and 12 months), and assuming a 
correlation between repeated measures of 0.7% and 90% 
power, requires 215 participants per arm. Allowing for 
20% lost to follow- up, this gives a total sample size of 806.
Data collection and management
Data are primarily being collected online. The LifeGuide 
intervention and data system collects consent, baseline 
data including demographics and follow- up data across 
the four time points (6 weeks, 3, 6 and 12 months). 
When first sent a link to the system following screening, 
if patients do not log on within a week, they are emailed 
to check that they received the link and advised to look 
in their spam mail. If there is no response, one telephone 
call is attempted by the research team.
With regard to follow up protocol, where there is no 
response to the online follow- up questionnaire emails, two 
reminder emails and text messages will be sent. Following 
continued non- response, a paper questionnaire pack 
with a prepaid envelope will be sent 1 week after the last 
email/text reminder. If the paper questionnaires are not 
returned within 2 weeks of being sent, a blinded research 
assistant will call the participant to complete the primary 
outcome measure (RMDQ), quality of life questionnaire 
(EQ- 5D- 5L) and pain severity. If the participant is happy 
to continue, further measures from the questionnaire 
battery at the respective follow- up point will be collected 
in this manner. The full follow- up protocol with the tele-
phone calls will be implemented at 6 weeks and 12 months 
follow- up points. These two follow- up points are consid-
ered most important, capturing initial and long- term 
response. Calling at all time points may lead to increased 
dropout at later time points. Follow- up at 3 and 6 months 
will include all the above steps except for the phone calls. 
All participants will receive a £5 voucher when asked to 
complete questionnaires at the more distant time points 
of 6 and 12 months. Examples of data collection forms 
can be provided by the trial team on request.
Statistical methods
Quantitative analysis will begin following cleaning 
and inspection of the data. Descriptive analysis will be 
conducted to determine outliers and distributions of the 
data. Where necessary, if data are not normally distrib-
uted, transformations will be applied or another appro-
priate distribution used. The primary analysis for the 
RMDQ score will be performed using a multilevel mixed 
model framework with observations at 6 weeks, 3, 6 and 
12 months (level 1) nested within participants (level 2). 
Results will be reported adjusting for baseline severity 
in function, stratification factors and any prespecified 
confounders. The model will use all the observed data 
and makes the assumption that missing RMDQ scores are 
missing at random given the observed data.
As there may not be a constant treatment effect over 
time, a treatment/time interaction will be modelled and 
included if significant (at the 5% level), with time treated 
as a random effect. An unstructured covariance matrix 
will be used.
Analysis of secondary outcomes will also be conducted 
using linear regression for continuous outcomes and 
logistic regression for dichotomous outcomes, again 
controlling for baseline symptom severity, stratification 
factors and any potential confounders. The structure and 
pattern of missing data will be examined, if appropriate, 
and a sensitivity analysis based on data imputed using a 
multiple imputation model presented. Data will be anal-
ysed on an intention- to- treat basis (they will be analysed as 
randomised). We will also undertake a complier- average 
causal effect analysis,37 which compares compliant partic-
ipants in the intervention group, with those in the control 
group whose characteristics are similar enough to the 
intervention group compliers to suggest they too would 
have complied with the intervention, given the opportu-
nity to do so. Compliance for these analyses in the inter-
vention arm will be defined as completing at least session 
1 of the internet intervention. Session 1 contains the 
central rationale for the intervention; that PA is primary 
in the management of LBP and provides instructions 
and advice on goal setting. The latter sessions follow a 
similar format to the first introductory module. With 
regard to the physiotherapist telephone support arm, 
we consider per protocol to be receiving at least two of 
the three planned phone calls. The telephone element is 
designed to be pragmatic with the necessary flexibility to 
fit patients’ requirements. However, receiving at least two 
of three calls indicates that support was delivered over 
time; an important aspect in the design and integration 
with the internet intervention.
Domain Measure Time point
Occupational impact of LBP Brief occupational questionnaire 
developed for this trial.
12 months.
All arms.
Use of internet resources
Use of internet resources Single item regarding use of internet 
resources for LBP over trial period.
12 months.
All arms.
LBP, low back pain; NHS, National Health Service.
Table 1 Continued
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It is not anticipated that there will be significant prac-
tice level (cluster) effects but this assumption will be 
tested by comparing a fixed effect model to a random 
effects model. If there are significant practice level effects 
then, the model will include a random effect for practice 
(random intercept) and participant (random intercept 
and slope on time) to allow for between participant and 
practice differences at baseline and between participant 
differences in the rate of change over time (if significant 
at the 5% level), and fixed effects for baseline covariates.
No interim analyses are planned. Full details of the 
analyses to be undertaken will be set out in the statistical 
analysis plan and approved by the trial steering committee 
(TSC). Our full statistical analysis plan will be published 
on the trial website in due course (https://www. south-
ampton. ac. uk/ medicine/ academic_ units/ projects/ 
supportback2. page).
Cost-effectiveness analysis
A ‘within- trial’ economic analysis will be conducted along-
side the RCT to estimate the incremental cost- effectiveness 
of the SupportBack 2 interventions compared with usual 
care. The base case perspective will be that of the NHS, 
but other resources relevant to LBP will be collected to 
enable additional analysis from a societal perspective.
The main outcome measure in the economic evaluation 
will be the quality- adjusted life year (QALY), obtained 
from the EQ- 5D- 5L instrument using the published UK 
value set. In addition, a cost- effectiveness analysis will be 
carried out using the study primary outcome measure, 
that is, the cost per point change in back- related physical 
function measured using the RMDQ will be estimated. 
Both costs and effects will be estimated using multiple 
regression, to allow for potential confounders, such as 
baseline scores for EQ- 5D- 5L and RMDQ. Standard 
practice will be followed to calculate incremental cost- 
effectiveness ratios (ICERs), and present ICER(s) where 
any one option has both higher costs and increased 
effects compared with another. ICERs will show incre-
mental cost per QALY or incremental cost per point 
improvement in RMDQ. Bootstrapping will be used to 
calculate cost- effectiveness acceptability curves. These 
will illustrate the effect of uncertainty on study results. 
Major assumptions made in the analysis will be tested by 
means of sensitivity analysis. In particular, assumptions 
made during the costing of the intervention such as the 
number of individuals who will be using the website will 
be explored. Similar methods to the main clinical anal-
ysis will be used to handle missing data, that is, analysis 
of patterns of missing data with multiple imputation 
methods employed if deemed appropriate. The proposed 
health economics analysis will be detailed in a health 
economics analysis plan (HEAP) which will be completed 
before analysis commences. The HEAP will be circulated 
for comment prior to the health economics analysis. Any 
digressions from the HEAP will be documented and justi-
fied in the final health economics report.
Process evaluation
A process evaluation will be carried out following Medical 
Research Council guidelines on process evaluations of 
complex interventions.38 In order to provide a detailed 
understanding of the SupportBack intervention three 
aspects will be examined: Implementation, mechanisms 
of impact (mediators) and context (moderators). A 
mixed- methods approach will be used to explore these 
elements.
Implementation
Quantitative data describing trial implementation will 
be presented including number of practices recruited, 
patient eligibility (including reasons for declined partic-
ipation where possible, and analysis of screen failures) 
and recruitment rates. The number of withdrawals from 
the trial per arm will be presented, along with numbers/
percentages of drop- outs from the intervention who do 
not respond to follow up. Use of the internet intervention 
will be described by presenting automated data collected 
on number of logins and modules accessed for both the 
internet intervention and the intervention plus telephone 
physiotherapist support arm. With regard to the internet 
intervention plus telephone physiotherapist support 
arm, the number of support calls successfully made 
(and attempts contact the patient), along with the mean 
number per participant in this arm will be described.
Qualitative interviews will be conducted with up to 
45 trial participants following the 3, 6 and 12 months 
follow- up points. Different participants will be interviewed 
at each time point, enabling us to explore how time since 
accessing the tailored weekly component of the interven-
tion effects how suggestions are used and implemented in 
daily life. Interviews will also be conducted with the trial 
physiotherapists. Participants will be purposively sampled 
to ensure diversity in terms of age, sex and symptom 
severity (physical function, pain intensity and duration). 
Participants will also be sampled based on high and low 
usage of the internet intervention and high and low 
engagement with the telephone physiotherapist support. 
For participants, questions will focus on their experience 
of using the intervention, including telephone physio-
therapist support and usual care. Interviews with the trial 
support physiotherapists will be designed to explore their 
experience of delivering the intervention, with a partic-
ular focus on barriers and facilitators, and determinants 
of successful exchanges.
Mechanisms of impact
A logic model of proposed mechanisms affecting LBP- 
related physical disability and pain outcomes for the 
SupportBack intervention has been developed (see 
ref.14). This model will be used as the basis of both 
quantitative and qualitative exploration of mecha-
nisms. Quantitative analyses will focus on psycholog-
ical and behavioural mechanisms influencing outcome 
following use of the interventions including expectancy, 
self- efficacy, PA, self- reported goal setting across the 
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intervention and objective measures of intervention 
use (sessions completed, use of additional modules, 
for example, mood, sleep etc). In order to explore 
whether two core mechanisms’ (mediating variables) 
contribution to outcome is unique to the internet inter-
vention arms, brief single items capturing SE and PA 
are being measured in all three arms (including usual 
care). SE and PA are being measured at baseline and in 
the outcome questionnaire sets at 6 weeks, 3, 6 and 12 
months. Mediation analysis will be used to explore rela-
tionships between mediating variables and LBP- related 
physical function and pain intensity across the 12- month 
follow- up period. We will also explore the potential of 
multilevel modelling to examine mediating variables 
association with the outcome over time.39 Appropriate 
checks of the assumptions of causal modelling, such as 
exchangeability (no confounding), consistency, effect 
modification and temporality will also be carried out.40 41
Questions will be included in the qualitative interviews 
focusing on participants’ perceptions of how use of the 
SupportBack intervention and/or telephone support 
affected their LBP. This will enable the inductive explo-
ration of participants’ views and triangulation of qualita-
tively derived theory on mechanism with our quantitative 
analysis. Similar questions will also be explored in the 
usual care arm, focusing on how elements of their usual 
care may have led to improvements in their LBP.
Context
The relationship between elements of participants’ 
context (moderators) and the effect of the interventions 
across the 12 months follow- up period will be explored. 
This will include variables such as LBP severity and dura-
tion at baseline, age, educational level and occupation 
status. Following the analysis of mechanisms, correlations 
and multiple regression (linear and logistic) will be used 
to explore relationships between moderating variables 
and LBP- related physical function and pain intensity. 
Qualitatively, the above aspects of participants’ context, 
including their own descriptions of their LBP history, 
will feed into analysis when exploring themes regarding 
participants use of the intervention and their perceptions 
of benefit.42
Qualitative analysis
Interview data collected regarding implementation, 
mechanisms and context will be transcribed verbatim, 
coded and analysed using an inductive thematic analytic 
approach.43 44 This will ensure participants’ qualitative 
data are not constrained by the direction of a partic-
ular theoretical model, and enable novel insights from 
qualitative work to be added into the theory- driven 
logic model. A key aspect of the qualitative analysis will 
entail exploring differences in accounts at different 
time points. This will enable us explore how time since 
the tailored weekly sessions impacts on the process of 
self- management.
Data monitoring and confidentiality
The SupportBack 2 trial has a data monitoring and ethics 
committee (DMEC) composed of a statistician (chair) 
and two academic clinicians (Professor in Primary Care 
Research and Professor of Physiotherapy respectively). 
The DMEC reports to the TSC and is fully independent 
from the trial Sponsor with no competing interests. 
Interim descriptive analyses are prepared for the DMEC. 
The DMEC charter can be obtained from the research 
team on request.
All serious adverse events (SAEs) are reported to the 
lead clinical trial unit. The assessment of seriousness will 
be made by the participants GP or delegate. Assessment of 
causality will be made by the GP or delegate, and related 
or unrelated status will be determined. As the Support-
Back intervention provides reassurance and encourages 
gentle activity within the participants’ own limits, there 
are no ‘expected’ SAEs documented.
All patient data are being kept in strict confidence and 
managed in accordance with the Data Protection Act 2018 
and General Data Protection Regulation (2018) legislation. 
The University of Southampton policy on archiving will 
be followed; the data will be stored for 10 years following 
the end of the study, after which time it will be disposed 
of securely. Following completion of the trial, a cleaned 
anonymised data set will be shared on request.
Patient and public involvement
Patient representatives have been involved with the Support-
Back trials from the outset. The idea for the trials and their 
subsequent design was informed by the local branch of the 
national charity BackCare. From this group, LL joined the 
research team and contributed to funding applications for 
both feasibility and main trials. SupportBack 2 has a panel 
of three patient and public involvement (PPI) representa-
tives who are part of the trial management group, advising 
on patient facing materials and contributing to discussions 
of trial related issues as they arise. PPI will pay a key role in 
dissemination of trial findings and interpretation of quali-
tative data.
Ethics and dissemination
The SupportBack 2 trial has received full ethical approval 
form a local review board (REC Ref: 18/SC/0388). All 
potentially eligible patients receive a patient information 
sheet. This information emphasises that participation in 
the trial is voluntary and that the participant may withdraw 
from the trial at any time for any reason. The participants 
are given the opportunity to ask any questions that may 
arise by speaking with the trial team and time to consider 
the information fully prior to agreeing to participate.
The findings of this trial will be published in peer- 
reviewed journals and presented at international confer-
ences. We will develop press releases in order to disseminate 
the findings to the general public, and work closely with 
our PPI collaborators to ensure dissemination to patient 
and other special interest groups. A summary of the find-
ings will be sent to all included general practices and those 
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patients that request this information. If the intervention 
is shown to be effective, we will work with developers to 
rapidly develop a version for widescale dissemination and 
implementation.
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